Home > Press > Millipore Corporation and Guava Technologies to Award Instrumentation to Advance Cell Biology Research
Abstract:
Millipore Corporation and Guava Technologies announced today they will jointly award a Guava® flow cytometer instrument valued at over $100,000 USD to a scientist whose innovative research proposal will advance the understanding of cell biology.
The award was announced during the American Society of Cell Biology meeting in San Francisco, California by Geoffrey Crouse, Vice President, Millipore Life Science and Lawrence Bruder, CEO, Guava Technologies.
"This award will enable research into such critical areas of cell biology as stem cell differentiation, cell signaling, mechanism of action of a particular therapeutic agent, and insight into the molecular basis of a specific pathology," said Crouse.
Applications can be accessed from both the Millipore and Guava Technologies web sites from January 1 until April 30, 2009 (www.millipore.com and www.guavatechnologies.com). The applications will be reviewed by a joint panel of scientists from both companies. After reviewing the applications, the scientific panel will select five finalists. Each of the finalists will be contacted for an in-depth discussion of their proposal. The instrument will be awarded in May, 2009 to one of the finalists. The award is open to all research labs worldwide.
"This is a partnership—not just between Millipore and Guava Technologies, but between our two companies and the research community," said Bruder. "Millipore's expertise in fluorescent antibody kit development and assay validation combined with Guava Technology's expertise in flow cytometry instrumentation and software is enabling more researchers than ever before to access this powerful technology."
Earlier this year, Millipore and Guava Technologies entered into a long-term partnership to deliver optimized benchtop flow cytometry products and services to the academic, government, biotechnology, and pharmaceutical markets.
Since the partnership was announced, the companies have successfully launched 17 kits for stem cell characterization and chemokine receptor quantification and are jointly developing a next generation flow cytometry instrument.
####
About Millipore Corporation
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with 6,000 employees in 47 countries worldwide. For more information, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visit www.millipore.com.
About Guava Technologies
Guava Technologies, Inc. is a private biotechnology and medical device company that designs and manufactures easy-to-use, on-demand, benchtop cell analysis systems. The company has ISO13485 certification for design and manufacture of medical devices. All Guava Flow Cytometers are compatible with an ever-increasing array of turnkey assays that include optimized reagents and assay-specific software to address applications such as cell counting/viability, antibody quantification, cell cycle and proliferation, cytotoxicity, apoptosis, and more. By delivering total cell analysis solutions that minimize time from hypothesis to conclusion, Guava Technologies helps scientists understand life one cell at a time. The company’s user base continues to grow steadily as customers recognize the value of this approach.
Millipore is a registered trademark and the “M” logo is a trademark of Millipore Corporation.
Guava is a registered trademark of Guava Technologies.
For more information, please click here
Contacts:
Millipore Media Contact
Greg Hoff
978-762-5170
or
Guava Media Contact
Corporate Communications
510-576-1394
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Atomic force microscopy in 3D July 5th, 2024
Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||